S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

$20.19
-0.59 (-2.84%)
(As of 03/4/2024 ET)
Today's Range
$19.98
$21.20
50-Day Range
$19.70
$32.47
52-Week Range
$15.10
$39.05
Volume
2.56 million shs
Average Volume
1.91 million shs
Market Capitalization
$3.00 billion
P/E Ratio
N/A
Dividend Yield
4.95%
Price Target
$30.67

Chemours MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
51.9% Upside
$30.67 Price Target
Short Interest
Healthy
3.16% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.11mentions of Chemours in the last 14 days
Based on 58 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
14.75%
From $2.78 to $3.19 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.55 out of 5 stars

Basic Materials Sector

69th out of 169 stocks

Chemicals & Allied Products Industry

9th out of 16 stocks


CC stock logo

About Chemours Stock (NYSE:CC)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Stock Price History

CC Stock News Headlines

CC Apr 2024 23.000 call
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
CC Apr 2024 29.000 call
CC Apr 2024 17.000 put
CC Jul 2024 19.000 put
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
CC Apr 2024 24.000 put
BMO Capital Markets Lowers Chemours (NYSE:CC) to Underperform
CC Mar 2024 24.000 call
CC Mar 2024 22.000 put
CC Oct 2024 35.000 put
CC Mar 2024 38.000 call
Chemours Stock Gains After Bruising Thursday
Chemours Co.
Chemours Target of Unusually Large Options Trading (NYSE:CC)
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/28/2023
Ex-Dividend for 12/15 Dividend
11/14/2023
Dividend Payable
12/15/2023
Ex-Dividend for 3/15 Dividend
2/23/2024
Today
3/04/2024
Dividend Payable
3/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.67
High Stock Price Target
$43.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+47.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

Net Income
$578 million
Pretax Margin
-5.10%

Debt

Sales & Book Value

Annual Sales
$6.79 billion
Cash Flow
$6.88 per share
Book Value
$7.34 per share

Miscellaneous

Free Float
146,018,000
Market Cap
$3.09 billion
Optionable
Optionable
Beta
1.97
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report














CC Stock Analysis - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price target for 2024?

7 Wall Street research analysts have issued 1-year price targets for Chemours' shares. Their CC share price targets range from $19.00 to $43.00. On average, they expect the company's stock price to reach $30.67 in the next twelve months. This suggests a possible upside of 51.9% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2024?

Chemours' stock was trading at $31.54 on January 1st, 2024. Since then, CC stock has decreased by 36.0% and is now trading at $20.19.
View the best growth stocks for 2024 here
.

Are investors shorting Chemours?

Chemours saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 4,640,000 shares, a decline of 5.9% from the January 31st total of 4,930,000 shares. Based on an average daily trading volume, of 1,170,000 shares, the days-to-cover ratio is presently 4.0 days. Approximately 3.2% of the shares of the company are sold short.
View Chemours' Short Interest
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) posted its earnings results on Friday, July, 28th. The specialty chemicals company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.01. The specialty chemicals company earned $1.64 billion during the quarter, compared to analyst estimates of $1.75 billion. Chemours had a negative net margin of 5.13% and a positive trailing twelve-month return on equity of 42.13%. During the same quarter last year, the company posted $1.89 earnings per share.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours announced a quarterly dividend on Monday, February 12th. Shareholders of record on Monday, February 26th will be paid a dividend of $0.25 per share on Friday, March 15th. This represents a $1.00 annualized dividend and a yield of 4.95%. The ex-dividend date is Friday, February 23rd.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 4.81%. CC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CC.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY 2023 earnings guidance on Thursday, February, 29th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $6.0 billion-$6.0 billion, compared to the consensus revenue estimate of $6.0 billion.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.80%), Massachusetts Financial Services Co. MA (3.21%), Dimensional Fund Advisors LP (1.72%), LSV Asset Management (1.59%), Vaughan Nelson Investment Management L.P. (0.93%) and Norges Bank (0.84%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CC) was last updated on 3/4/2024 by MarketBeat.com Staff